NCT03128138View on ClinicalTrials.gov

Single Ascending Dose Study of Safety and Tolerability of SPH3127 Tablet in Chinese Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

July 30, 2018

Conditions
Hypertension
Interventions
DRUG

SPH3127

"Drug: SPH3127 Tablet~Drug: Placebo Tablet"

Trial Locations (1)

100029

The capital medical university affiliated Beijing anzhen hospital, Beijing

All Listed Sponsors
lead

Shanghai Pharmaceuticals Holding Co., Ltd

INDUSTRY

NCT03128138 - Single Ascending Dose Study of Safety and Tolerability of SPH3127 Tablet in Chinese Healthy Volunteers | Biotech Hunter | Biotech Hunter